Vyne Therapeutics Inc (VYNE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.59
• Market Cap: $19.51M
• EPS: $-0.79
• 52-Week High: $2.60
• 52-Week Low: $0.28

About Vyne Therapeutics Inc

Vyne Therapeutics Inc. is a biopharmaceutical company based in Bridgewater, New Jersey, focused on creating innovative therapies for dermatological conditions. With a promising pipeline targeting significant unmet medical needs in skin diseases, the company employs its proprietary technology and therapeutic platforms to enhance its treatment solutions. Vyne's dedication to advancing the management of dermatological disorders underscores its potential to improve patient outcomes and quality of...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Vyne Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VYNE pay dividends?

Vyne Therapeutics Inc (VYNE) does not currently pay a regular dividend.

What is VYNE's market cap?

Vyne Therapeutics Inc (VYNE) has a market capitalization of $19.51M with a current stock price of $0.59.